Skip to content
OpenCapital
Get started

Bio-Rad Laboratories BIO Life Science — Gross Profit

Other segment segments

Clinical Diagnostics
$181.8M+2.4%

Similar metrics at other companies

Revvity logo
RVTYLife Sciences — Segment operating income
$103.98M-1.6%
STERIS logo
STELife Sciences: — Segment operating income
$61.8M+6.4%
Revvity logo
RVTYLife Sciences — Reportable segment operating income (loss)
$102.98M-9.8%
Globe Life logo
GLLife — Gross Profit
$387.18M+29.0%
STERIS logo
STELife Science Member — Segment operating income
$58.13M+2.5%
PEA
PEAKLifescience — Profit Loss
——

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:GrossProfit.

The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories's life science — gross profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories's life science — gross profit?
Bio-Rad Laboratories (BIO) reported life science — gross profit of $127.6M in Q1 2026.
How has Bio-Rad Laboratories's life science — gross profit changed year-over-year?
Bio-Rad Laboratories's life science — gross profit decreased by 0.6% year-over-year, from $128.4M to $127.6M.
What is the long-term trend for Bio-Rad Laboratories's life science — gross profit?
Over 3 years (2022 to 2025), Bio-Rad Laboratories's life science — gross profit has grown at a -12.1% compound annual growth rate (CAGR), from $814.5M to $553.1M.
What does life science — gross profit mean?
The profit remaining from Life Science sales after paying for the direct costs of production.
How do you interpret life science — gross profit?
Higher gross profit indicates strong pricing power or efficient production processes.
How does life science — gross profit compare across companies?
Core profitability metric used to compare the manufacturing efficiency of different business segments.